ISSN: 2332-0877

Journal of Infectious Diseases & Therapy
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Short Communication   
  • J Infect Dis Ther,

Dual Effect of Auranofin Drug on SARS-CoV-2

Emmanuel Laplantine1,2, Delphine Muriaux3,4 and Robert Weil1*
1Center for Immunology and Infectious Diseases, Sorbonne Universities, National Institute of Health and Medical Research, National Center for Scientific Research, Paris, France
2Divison of Infectious Diseases, St. Louis Research Institute, St. Louis Hospital, University of Paris, Paris, France
3Department of Pathology, Montpellier University, Montpellier, France
4Department of Pathology, Institute of Research in Infectiology of Montpellier (IRIM), University of Montpellier, Montpellier, France
*Corresponding Author : Robert Weil, Center for Immunology and Infectious Diseases, Sorbonne Universities, National Institute of Health and Medical Research, National Center for Scientific Research, Paris, France, Email: Robert.weil@upmc.fr

Received Date: Feb 02, 2023 / Published Date: Mar 07, 2023

Citation: Laplantine E, Muriaux D, Weil R (2023) Dual Effect of Auranofin Drug on SARS-CoV-2. J infect Dis Ther S1:003.

Copyright: © 2023 Weil R. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top